Drawing for BIONNOVATION

USPTO serial 99424692

BIONNOVATION

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
ALTREE, NICHOLAS
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with BIONNOVATION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

LEO M. LOUGHLIN

LEO M. LOUGHLIN ROTHWELL, FIGG, ERNST & MANBECK , PC901 New York Avenue, NWSuite 900 EastWashington, DC 20001

Goods and services

ClassDescriptionStatusFirst use
005Taurolidine containing pharmaceutical and veterinary preparations and substances for prevention or treatment of periodontitis or peritonitis; sanitary preparations for medical purposes; hemostatics for medical purposes; wound dressing material; wound sponges impregnated with antiseptics; medical adhesives for binding internal tissue; medical plasters; pharmaceutical preparations for the treatment of wounds and ulcers, and diabetic ulcers, and for the treatment of orthopedic conditions, namely, cartilage defects, meniscus injuries, and ligament injuries; material for filling teeth and materials for dental impressions; ceramics and cement for teeth and bones for orthopedic and surgical use; disinfectants; biological membrane and noncollagen tissues intended for subsequent implantation; surgical collagen implants; surgical collagen adhesive dressings; natural biomaterials for augmentation of bone and tissue for medical purposes; natural bone implant materials, namely, biological bone tissueACTIVE—
010Surgical, medical, dental and veterinary apparatus and instruments in the nature of resorbable implants composed of artificial materials; orthopedic articles in the nature of resorbable implants composed of artificial materials; fillers and implants composed of artificial materials for use in dental, maxillofacial and orthopedic surgery for the regeneration of bone and soft tissue filling and implant materials derived from natural substances for dental, maxillofacial and orthopedic surgery, especially for the regeneration of bone and soft tissue; biocompatible collagen-material, namely, biocompatible collagen barrier membranes, biocompatible collagen-matrixes, and biocompatible collagen-sponges for use in dental, maxillofacial and orthopedic surgery, for the regeneration of bone and soft tissue, or for use as a hemostatic agent in the surgery and dressing; artificial teeth; artificial jaws; dentures; sets of artificial teeth; prostheses for dental purposes and orthopedic purposes, namely, dental prostheses and joint prostheses; teething rings; surgical implants composed of artificial materials; dental drills; dental appliances, namely, ultrasound appliances for dental use; electrical dental instruments, namely, dental drills, dental handpieces, and ultrasonic dental scalers; surgical drills; milling apparatus for dental purposes; surgical instruments, namely, contra-angles, surgical engines, implant stability gauges; custom dentures; synthetic bone grafts; artificial biomaterials for augmentation of bone and tissue for medical purposes; dental equipment, namely, personal protective equipment in the nature of face shields; prosthetic components, namely, cushion liners for prosthetic limbs; surgical instrumentsACTIVE—
041Organization of seminars, workshops, training and continuing education courses in the fields of application of taurolidine, sanitary preparations, wound dressing material, wound sponges, medical adhesives, filling and implant materials, medical plasters, biocompatible collagen-material, in particular biocompatible collagen-membranes, biocompatible collagen-matrixes or biocompatible collagen-sponge, surgical collagen-implants, surgical collagen-adhesives, resorbable implants for use in dental, maxillofacial, orthopedic or visceral surgeryACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
Sep 8, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 14, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 14, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 8, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 16, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 16, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 16, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 16, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 13, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 13, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 13, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2026DOCKASSIGNED TO EXAMINER—
Feb 11, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 2, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 2, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance